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INTRODUCTION 
Class I phosphatidylinositol 3-kinases (PI3Ks) are responsible 
for conversion of PtdIns4,5P2 into PtdIns3,4,5P3 in eukary-
otic cells. Inhibitors of this enzymatic activity have thor-
oughly been sought, as its product is a second messenger 
involved in proliferative, anti-apoptotic and inflammatory 
pathways, among others [1]. By heterologous expression in 
the Saccharomyces cerevisiae eukaryotic unicellular model, 
which naturally lacks such PI3K activity, we have previously 
engineered a system to in vivo titrate the activity of patho-
logic mutant versions of components of the human PI3K 
pathway, namely the p110α catalytic [2-4] and p85 regula-
tory subunits [5] that conform the class IA PI3K, its main  
effector Akt [4, 6] and its key down-regulator, the tumor 
suppressor PTEN [7, 8]. In order to meet its substrate, the 
PI3K p110α catalytic subunit must be directed to the plasma 
membrane (PM). In mammalian cells, spatial regulation oc-
curs by recruitment via the p85 regulatory subunit, which 
recognizes phospho-Tyr residues generated by local ligand-
mediated activation of tyrosine kinase-coupled receptors [9, 
10]. The PI3K effector Akt1 is subsequently anchored to the 
PM via its PtdIns3,4,5P3-binding PH domain, where it is acti-
vated by phosphorylation at different sites by PDK1 and the 
TORC2 complex [10, 11]. In our yeast engineered model, PM 
tethering of the p110α catalytic subunit is achieved by  
adding N-terminal myristoylation or C-terminal CAAX 
prenylation signals to this protein [4, 5]. Reconstitution of 
class IA PI3K activity by this means results in yeast growth 
inhibition as a consequence of the withdrawal of essential 
PM PtdIns4,5P2 pools [12], as well as in localization and en-
hanced phosphorylation of Akt1 at the PM due to the  
production of PtdIns3,4,5P3 [6]. Remarkably, expression of 
neither naked (non PM-directed) p110α nor Akt1 alone in 
yeast leads to growth defect, whereas co-expression of both 
heterologous proteins inhibits yeast growth in an Akt cata-
lytic activity-dependent manner as a consequence of the in-
terference of active Akt with yeast TORC2 signaling [13]. 
Thus, even in the absence of the p85 regulatory subunit or 
artificial targeting to the yeast PM, p110α can produce 
enough PtdIns3,4,5P3 to efficiently relocate and activate Akt. 
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ABSTRACT  Phosphatidylinositol 3-kinase (PI3K) is a key regulator of phosphoinosi-
tide-dependent signaling in mammalian cells and its dysfunction is related to mul-
tiple syndromes, including cancer. By heterologous expression in Saccharomyces 
cerevisiae, we have developed a humanized yeast system as a tool for functional 
studies on higher eukaryotic PI3K. Here we restrict PI3K activity in yeast to specific 
plasma membrane (PM) microdomains by fusing the p110α PI3K catalytic subunit 
to either a septin or an eisosome component. We engineered a Dual Reporter for 
PI3K (DRAPIK), useful to monitor activity on cellular membranes in vivo at a single-
cell level, by simultaneous PM staining of the enzyme substrate (PtdIns4,5P2) with 
GFP and its product (PtdIns3,4,5P3) with mCherry. We also developed a sensitive 
FLUorescence by PI3K Inhibition (FLUPI) assay based on a GFP transcriptional re-
porter that is turned off by PI3K activity. This reporter system proved useful to mon-
itor PI3K inhibition in vivo by active compounds. Such novel tools were used to 
study the performance of yeast PM microdomain-directed PI3K. Our results show 
that tethering heterologous PI3K to discrete PM domains potentiates its activity on 
PtdIns4,5P2 but different locations display distinct effects on yeast growth and en-
docytosis. 
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However, unlike myr-p110α and p110α-CAAX, naked p110α 
is not able to eliminate enough PtdIns4,5P2 from the yeast 
PM to compromise cell viability [5, 7]. 
Recent evidence suggests that the yeast PM is organized 
in microdomains and that PtdIns4,5P2 plays a role in config-
uring them [14, 15]. In turn, microdomains such as the ei-
sosome/MCC (Membrane Compartment containing Can1) 
are involved in the control of PtdIns4,5P2 levels [15-17]. 
Here, we have designed chimeras to fine-tune the localiza-
tion of heterologous PI3K activity in the yeast PM to two 
specific membrane microdomains that are stable along the 
budding cycle: the septin collar at the bud neck and  
eisosomes/MCCs. Moreover, in order to determine PI3K ac-
tivity in vivo at both single-cell and whole population levels, 
we have developed novel fluorescent protein-based report-
ers that accurately permit assessment of heterologous PI3K 
activity in the yeast model. 
 
RESULTS AND DISCUSSION 
Spatial targeting of PI3K activity to specific yeast PM  
microdomains 
N-terminal myristoylation or C-terminal prenylation signals, 
previously used to bring p110α in contact to its substrate [2, 
4, 5], should indiscriminately direct PI3K activity to any loca-
tion at the yeast PM. Instead, we decided to spatially  
modulate this activity to discrete domains in order to study 
the effects of locally enhanced conversion of PtdIns4,5P2 
into PtdIns3,4,5P3. Through the budding cycle, the stretch of 
PM that conforms the bud neck is tightly and stably marked 
by a highly structured ring of septin filaments consisting of 
Cdc3, Cdc10, Shs1, Cdc11 and Cdc12 [18]. Septins are 
PtdIns4,5P2-binding proteins and the interaction with this 
phosphoinositide promotes their assembly into filaments 
[19]. Therefore, we decided to specifically direct PI3K activ-
ity to the septin-delimited PM area. To this end we pro-
duced a chimera consisting of the Cdc10 septin fused to the 
N-terminus of p110α. The Cdc10-p110α fusion protein re-
sulted inhibitory for yeast cell growth and its toxicity relied 
on p110α catalytic activity, as a kinase-dead Cdc10-
p110α(K802R) chimera was tolerated (Fig. 1A). To prove 
that Cdc10 in this sort of fusion was still tethered to the sep-
tin ring we developed a triple Cdc10-GFP-p110α chimeric 
protein. When expressed, this new chimera also inhibited 
yeast growth and specifically marked the bud neck (Fig. 1B-
C). Furthermore, a point mutation in Cdc10 (Gly179 to Asp, 
known as the cdc10-11 allele) which impairs its assembly at 
the ring [20, 21], led to loss of both localization (data not 
shown) and toxicity (Fig. S1A). These results implied that the 
toxicity caused by the septin-PI3K chimera relied on both 
the targeting to the septin ring, where the PI3K catalytic sub-
unit should be close to its substrate at the PM, and on 
PtdIns4,5P2 consuming-PI3K activity. Despite the purported 
importance of PtdIns4,5P2 in septin assembly [19], Cdc10-
p110α did not lead to phenotypes characteristic of loss of 
septin ring function [20], such as bud elongation (Fig. S1B). 
This observation hints that the PtdIns4,5P2 pool underlying 
septin filaments may not be accessible for PI3K or that 
Cdc10 and PI3K are competing for the binding to this pool. 
FIGURE 1: Effects on yeast growth of non-
targeted and targeted p110α versions. (A) 
Ten-fold serial dilutions of wild type YPH499 
cells bearing plasmids YCpLG-PI3Kα(K802R) 
[p110α(K802R)], YCpLG-PI3Kα (p110α), 
YCpLG-Cdc10-p110α(K802R) or YCpLG-
Cdc10-p110α, respectively. Cells were  
cultured at 30°C on SD (Glucose) or SG (Ga-
lactose) agar for induction of p110α expres-
sion. Expressed fusions are indicated in the 
corresponding sketches at the left. (B) Yeast 
agar drop growth assays as in (A), but of 
YCpLG-Cdc10-GFP-p110α(K802R) or YCpLG-
Cdc10-GFP-p110α representative trans-
formant clones. (C) Bright field and equiva-
lent GFP fluorescence microscopy images of 
cells expressing the triple fusion protein 
[Cdc10-GFP-p110α-WT]. The arrows indi-
cate localization at the septin ring at the 
mother-bud neck. The scale bar represents 
5 µm. (D) Yeast growth assay of representa-
tive transformant clones bearing plasmids 
YCpLG-Pil1-p110α(K802R) or YCpLG-Pil1-
p110α. (E) Growth of representative yeast 
clones expressing either wild type or C2-do-
main mutant (C2/4K-A) p110α versions of 
the Cdc10-p110α or Pil1-p110α fusion pro-
teins, from plasmids YCpLG-Cdc10-p110α, 
YCpLG-Cdc10-p110α C2/4K-A, YCpLG-Pil1-
p110α or YCpLG-Pil1-p110α C2/4K-A, as  
indicated.  
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We next tested whether Cdc10, when fused to the catalyti-
cally inactive p110α mutant (K802R), whose expression 
does not affect yeast growth, was able to complement a 
loss-of-function cdc10-11 mutant. The Cdc10-p110α(K802R) 
chimera was not able to support growth of this mutant at 
the restrictive temperature (Fig. S1C), suggesting that the 
presence of p110α bound to its C-terminus prevented Cdc10 
from playing its functional role at the septin filaments in 
spite of its proper localization.  
We then studied the influence of directing PI3K activity to 
the MCC. With this aim, we developed a second fusion by 
attaching to p110α the eisosome core component Pil1, an  
F-BAR domain-containing protein that binds curved furrow-
like MCC microdomains [22]. As shown in Fig. 1D, tethering 
p110α to the eisosomes also led to growth inhibition, alt-
hough to a lesser extent than that caused by Cdc10-p110α. 
Expression of Pil1-p110α did not interfere with eisosome as-
sembly, since the localization of Sur7-GFP, a marker for 
these structures at the PM [23, 24], was apparently  
unaltered (Fig. S2A). Moreover, the kinase-dead Pil1-
p110α(K802R) chimera was unable to complement altera-
tions in eisosome assembly displayed by an lsp1∆ pil1∆  
double mutant. As in the case of Cdc10-p110α(K802R), loss 
of Pil1 function in Pil1-p110α(K802R) must be a conse-
quence of the bulky addition of p110 to its C-terminus, as 
restoration of a STOP codon (by site-directed mutagenesis 
in PIL1 at the site of the fusion with the p110α cDNA in our 
expression plasmid) led to a functional Pil1 (Fig. S2B).  
The p110α C2 domain is involved in PM recognition [25]. 
We previously showed that a quadruple mutation abolishing 
key positive charges within this domain (K410A, R412A, 
K413A, K416A), abrogated PI3K-dependent growth inhibi-
tion in our yeast model [5] when the interaction of p110α 
with the yeast PM was non-artificial, i.e., through recruit-
ment by the regulatory subunit p85α. In contrast, the robust 
attachment of p110α by the CAAX motif made this construct 
insensitive to these multiple C2 mutations [5]. Both Cdc10 
and Pil1 fusions to p110α seemed to mimic p85α function 
by bringing p110α in proximity to the PM, as the C2 domain 
of p110α was also necessary for the toxicity of these  
chimeras (Fig. 1E).  
In sum, synthetically directing p110α to discrete scaffolds 
at the yeast submembrane, such as the septin ring or the 
eisosomes, simulates physiological recruitment by the PI3K 
regulatory subunit in higher cells without apparently inter-
fering with the assembly and function of these structures, 
and leads to PtdIns4,5P2 depletion and toxicity due to PI3K 
activity. 
 
Differential effects on endocytosis of PI3K activity directed 
to septins vs. eisosomes  
Due to the essential role of PtdIns4,5P2 in endocytic path-
ways [26], expression of p110α-CAAX in yeast leads to an 
impairment of endocytosis, resulting in a defective internal-
ization of the endocytic marker FM4-64 [12]. By monitoring 
the incorporation of this fluorescent dye into vacuolar mem-
branes, the final destination of the endocytic pathway, we 
tested whether spatial direction of PI3K activity to either the  
 
septins or eisosomes would distinctly influence endocytosis, 
as compared to naked (non-membrane-directed), myristoy-
lated (myr-p110α) or prenylated (p110α-CAAX) versions of 
p110α. All active p110α versions negatively affected endo-
cytosis, being myr-p110α and Cdc10-p110α as efficient as 
p110α-CAAX (Fig. 2). Naked, non-PM-targeted p110α signif-
icantly decreased FM4-64 vacuolar labelling but was the less 
efficient version of p110α in doing so, as expected. Interest-
ingly, Pil1-p110α was not as competent as Cdc10-p110α  
inhibiting endocytosis, in agreement with its lower toxicity, 
suggesting that tethering PI3K to the eisosomes had less im-
pact in endocytosis than directing it to the bud neck. The 
role of eisosomes in endocytosis is controversial: while they 
were first described as sites of endocytosis [27], several re-
ports favor the hypothesis that they may negatively regulate 
endocytosis by sequestering endocytic components [28]. In 
fact, they have been related to down-regulation of 
PtdIns4,5P2 levels via recruitment of the phosphoinositide-
phosphatase Inp51/Sjl1 [17, 29]. Since Pil1-p110α, like 
Inp51/Sjl1, should locally deplete PtdIns4,5P2, it is conceiva-
ble that this fusion has less impact on endocytosis as  
compared to other PM-targeted p110α versions. In contrast,  
FIGURE 2: Endocytic fitness of non-targeted and various PM-
targeted p110α versions. (A) Bright field (left image) or fluores-
cence microscopy (right image) representative images of typical 
FM4-64 vacuolar staining in YPH499 cells expressing the kinase-
dead mutant p110α(K802R), 60 min after the addition of the vital 
dye. (B) Graphical representation of the percentage of cells 
(n ≥ 300) showing the aforementioned vacuolar staining pattern 
when expressing p110α(K802R), p110α-CAAX, p110α, myr-p110α, 
Cdc10-p110α and Pil1-p110α. Results displayed in the graphs cor-
respond to the mean of three biological replicates performed on 
different clones. Error bars represent the standard deviation (SD).
Asterisks (*, **, ***) indicate a p-value < 0.05, < 0.01, < 0.001 re-
spectively by the Student´s t-test, referred to p110α(K802R). Scale 
bars indicate 5 µm. 
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FIGURE 3: Dual Reporter for the Activity of PI3K (DRAPIK) strategy: a double marker to measure PtdIns4,5P2 and PtdIns3,4,5P3 at single-cell 
level. (A) Sketch of plasmid pJMCS-DM23, showing its main elements (left) and rationale and experimental design for the double marker 
analyses (right). Both fluorescent reporters are expressed simultaneously; yeast PM is rich in PtdIns4,5P2 and lacks PtdIns3,4,5P3, leading to 
recruitment of the green reporter to the PM whereas the red reporter remains cytoplasmic. Expression of PI3K should revert this situation 
proportionally to its enzymatic activity, the efficiency of its recruitment to the PM, and local substrate availability. (B) Representative fluores-
cence microscopy merged (red and green channels) images of YPH499 cells co-transformed with pJMCS-DM23 and expression plasmids for 
p110α(K802R), p110α-CAAX, p110α, myr-p110α, Cdc10-p110α and Pil1-p110α PI3K versions. Below, densitometric histograms showing the 
red (PtdIns3,4,5P3) and green (PtdIns4,5P2) fluorescence intensity in arbitrary units (au) along a transversal section of the cell, depicted above 
in white color, whose distance is represented in µm in abscissae. (C) Graph representing normalized red:green ratio [(PtdIns3,4,5P3) vs 
(PtdIns4,5P2)] for a population of individually monitored randomly chosen cells (n=90 per experiment) adjusted to a normal distribution. Cells 
co-express the same plasmids than in (B). The symbols *, ‡ and # express staWsWcal signiﬁcance when compared to p110α-KD, p110α-CAAX 
or Pil1-p110α, respectively (Bonferroni p-value < 0.01 for two symbols and < 0.001 for three). The symbols ▫ and ― represent the average and 
median values of the population; the colored boxes cluster the data between 25% and 75% of the population; the bars with a capped end (I) 
cluster the data between 5% and 95% of the population; the outlier data are represented by the symbol ∆. 
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septins provide an important spatial landmark for the clus-
tering of exo-endocytic machinery at the growing bud and 
at the septum [30], in consonance with a higher impact of 
PtdIns4,5P2 depletion on endocytosis from that spot. 
 
A tool for tracking PI3K activity in vivo at the single-cell 
level  
Once we had achieved subcellular targeting of heterologous 
p110α to discrete PM spots, we wondered whether this 
could lead to loss of particular PtdIns4,5P2 pools and spa-
tially restricted generation of PtdIns3,4,5P3. In order to in-
vestigate this, we developed a double fluorescent reporter 
vector for tracking PI3K activity in vivo at the single-cell level, 
by using the bidirectional expression vector pESC-TRP1 as a 
platform. This vector bears the GAL1-GAL10 co-inducible 
promoters facing opposing linkers. We fused two copies of 
the PH(PLCδ) PtdIns4,5P2-binding domain to GFP and the 
PH(Akt3) PtdIns3,4,5P3-binding domain to mCherry (Fig. 3A). 
In this fashion, the yeast PM would be stained in green in 
the absence of PI3K activity and the red marker would be 
recruited to the membrane only when PI3K was locally ac-
tive. We named this experimental setting Dual Reporter for 
the Activity of PI3K (DRAPIK). 
By fluorescence microscopy, we used DRAPIK to analyze 
the association of the green and red signals to the PM in 
yeast cells upon expression of various p110α versions. Rep-
resentative cells are shown in Fig. 3B. As expected, cells 
bearing control kinase-dead p110α (K802R) had their PM 
marked only in the green channel, whereas p110α-CAAX 
fully reversed this situation and displayed a predominant 
peripheral red signal, suggesting that virtually all 
PtdIns4,5P2 was turned into PtdIns3,4,5P3, in line with the 
high toxicity in yeast of this version of PI3K [4]. Naked p110α 
led to detectable conversion of PtdIns4,5P2 into 
PtdIns3,4,5P3, congruently with its effect on endocytosis fit-
ness shown above in Figure 2, and with its ability to activate 
its downstream kinase Akt through its PH domain, as previ-
ously reported [6, 13]. N-terminal myristoylation of p110α 
led to high red signal at the PM but it did not fully eliminate 
PtdIns4,5P2, as the green signal persisted, which explains 
why toxicity of myr-p110α in yeast is lower than that of 
p110α-CAAX [5] but higher than that of naked p110α. Pecu-
liarly, direction of PI3K activity to either the septin ring or 
eisosomes did not lead to obvious local patterns of green to 
red conversion at these sites by DRAPIK analysis, but rather 
gave also rise to general change of PtdIns4,5P2 into 
PtdIns3,4,5P3 along the whole PM. This likely denotes that 
phosphoinositides can readily diffuse in the PM even if their 
modifying enzymes are immobilized in particular spots.  
By analyzing individually a significant number of ran-
domly chosen cells per experiment (n = 90), normalizing PM 
vs. cytoplasmic fluorescence signals for each channel and 
calculating red:green ratios, we got average data for each 
p110α version (Fig. 3C). Despite cell-to-cell variability, all 
p110α versions except the kinase-dead control had 
red:green average ratios > 1, the highest corresponding to 
  
FIGURE 4: The FLUorescence by PI3K  
Inhibition (FLUPI) assay for the detec-
tion of heterologous PI3K activity by 
flow cytometry. (A) Sketches of plas-
mid pJMCS-LG3 bearing the transcrip-
tional activator construct and pGNG1 
(Mobitec) (left) and rationale of the 
system (right): the LexA-Gal4-
PH(Akt3) reporter is retained at the 
PM when the PI3K product 
PtdIns3,4,5P3 is present. Its release 
due to low PI3K activity or its inhibi-
tion should proportionally lead to nu-
clear translocation of the chimeric 
transcription factor and GFP expres-
sion. (B) On the left, stacked histo-
grams (n = 10,000) showing green  
fluorescence in abscissae of untrans-
formed YPH499 strain (No plasmids) 
and triple co-transformant clones 
bearing pJMCS-LG3, pGNG1 and either 
empty YCpLG (Vector) or expressing 
one of the PI3K versions: 
p110α(K802R)-CAAX, p110α-CAAX, 
p110α, myr-p110α, Cdc10-p110α or 
Pil1-p110α. On the right, graph show-
ing each population´s mean GFP fluo-
rescence (au) corresponding to the  
average of three biological replicates  
(n = 30,000). The asterisks (*) indicate 
a Bonferroni p-value < 0.001 vs. Vec-
tor; error bars represent SD. 
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p110α-CAAX and the lowest to naked p110α. These quanti-
tative  data  are  in  line  with our results above, indicating  a  
correlation between PI3K-driven yeast growth inhibition 
and endocytosis defects, with the intriguing exception of the 
eisosome- and septin-directed chimeras. Pil1-p110α pro-
duced a very efficient conversion of PtdIns4,5P2 to 
PtdIns3,4,5P3, similar to that of p110α-CAAX, whereas the 
septin-PI3K fusion did not eliminate all PtdIns4,5P2. This sug-
gests that there is a different requirement for PtdIns4,5P2-
dependent functions in the environment of each of the PM 
subdomains studied. Eisosomes are ubiquitous spots dis-
tributed around the whole PM. Thus, it is reasonable that 
Pil1-p110α leads to a higher red signal throughout the 
whole PM since PtdIns4,5P2-PtdIns3,4,5P3 conversion is 
likely taking place all over the yeast PM. In spite of this, pe-
culiarly, as discussed above, septin-directed PI3K activity, 
had a higher impact in endocytosis and viability than  
eisosome-directed PI3K. 
 
A tool for the study of PI3K activity in yeast cell populations 
that can be used to test PI3K inhibitors 
The simultaneous double phosphoinositide marker de-
scribed above allows single-cell analyses but was not ame-
nable for quantitative analyses in large cell populations. 
Thus, we designed a fluorescence-based strategy that would 
readily allow monitoring PI3K activity in yeast cultures by 
flow cytometry. We fused an artificial LexA-Gal4 chimeric 
transcriptional activator to the PtdIns3,4,5P3-binding PH do-
main of Akt3. In a strain co-transformed with a second plas-
mid bearing a transcriptional LexA-dependent GFP reporter 
and a third plasmid expressing p110α, the LexA-Gal4-
PH(Akt3) transcriptional activator would be sequestered at 
the PM by PI3K-generated PtdIns3,4,5P3 pool, precluding 
GFP expression. In contrast, yeast cells lacking PI3K activity 
would not retain the LexA-Gal4-PH(Akt3) fusion protein at 
the PM, allowing nuclear translocation and GFP expression 
(Fig. 4A). Since the system should lead to a gain of fluores-
cence upon PI3K inhibition, we named this experimental 
setting FLUorescence by PI3K Inhibition (FLUPI) assay. To 
test the system, we used as a proof-of-principle our collec-
tion of p110α versions. All active PI3K forms, regardless of 
the presence or absence of PM-directing signals, turned off 
GFP expression, showing a high sensitivity for detecting the 
presence of PtdIns3,4,5P3 at the PM and, therefore, PI3K ac-
tivity (Fig. 4B). This assay confirmed that Pil1-p110α was as 
efficient as p110α-CAAX in producing PtdIns3,4,5P3 in the 
yeast cells, in spite of its lower toxicity. 
Bioassays for PI3K inhibition are useful in drug discovery. 
We previously reported a growth-based assay using as a 
platform our humanized yeast system [3]. However, fluores-
cence-based assays are more sensitive and versatile. The 
above-described DRAPIK system could be useful to trace 
PI3K inhibition at a single-cell level but, as it requires micros-
copy, it would not be easily scalable to high throughput 
screening unless high content analysis platforms were used. 
On the contrary, the FLUPI assay described here might be 
optimum for this purpose. Since unmodified p110α led to 
significant GFP fluorescence shutting off, we considered 
that this version of p110α should be more suitable for a sim-
ple PI3K inhibition assay as compared to the artificially PM-
targeted p110α versions tested above. Thus, we tested in a 
FLUPI assay based on bare p110α a series of available chem-
ical inhibitors for their ability to recover GFP fluorescence, 
namely LY294002 [31], the isoform-specific p110α inhibitors 
FIGURE 5: Dose-response graphs 
showing enhancement of fluo-
rescence by the FLUPI assay.  
Triple pJMCS-LG3, pGNG1 and 
YCpLG-p110α YPH499 trans-
formants were analyzed by flow 
cytometry as in Fig. 4B in the pres-
ence of different doses of inhibi-
tors as noted. The abscissae  
represent fold increase in green 
fluorescence of treated samples 
with the indicated concentrations 
of compounds LY294002 (A), 15e 
(B), GDC-0326 (C) and ZSTK474 
(D) relative to their correspond-
ent DMSO alone control (normal-
ized to 1). Three different clones 
were analyzed per experiment  
(n = 10,000 cells per clone). Data 
correspond to the average, and 
error bars represent SD. Asterisks 
(*) mark data points that are sta-
tistically significant respective to 
the data of the lowest concentra-
tion of compound tested in each 
series, according to Student´s  
t-test (p < 0.05). 
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15e [32] and GDC-0326, a benzoxazepin derivative [33], and 
the isoform-nonspecific triazine derivative ZSTK474 [34]. For  
all four compounds, a dose-dependent enhancement of flu-
orescence was observed in the range of concentrations 
tested (Fig. 5). As compared to the previously reported 
growth recovery assay on yeast expressing p110α-CAAX [3], 
in which we had also tested the LY294002, 15e and ZSTK474 
inhibitors, the FLUPI assay also proved sensitive in the µM 
range for these compounds. Like in the previous setting, 15e 
was the most potent, leading to significant fluorescence in-
crease at lower concentrations, whereas LY294002 required 
higher concentrations to reach the same effect. Fluores-
cence increase for GDC-0326 and ZSTK474 was more mod-
est, but the latter was more efficient at low concentrations, 
similar to its performance in the growth recovery assay [3]. 
These data demonstrate the efficiency of the FLUPI bioassay 
to potentially screen for PI3K inhibitors on unmodified 
p110α using fluorescence-based strategies, suitable for mi-
crofluidics or other high-throughput platforms. 
In sum, we have designed a toolkit for studying class IA 
PI3K in a versatile humanized yeast model that permits (i) 
directing PI3K activity to discrete localizations at the PM, (ii) 
monitoring its activity at the single-cell and population lev-
els, and (iii) studying its pharmacological inhibition in vivo. 
These experimental settings broaden the experimental pos-
sibilities offered by the yeast cellular model on molecular 
and pharmacological studies based on this key oncoprotein. 
 
MATERIALS AND METHODS 
Strains, culture media and growth conditions 
Yeast strains used in this work are listed in Table S1. YPD [1% 
(w/v) yeast extract, 2% (w/v) peptone and 2% (w/v) glucose] 
broth or agar was used for yeast growth as a general non-selec-
tive medium. Synthetic dextrose (SD) medium consisted of 
0.17% yeast nitrogen base without amino acids, 0.5% ammo-
nium sulfate, 2% glucose and 0.12% synthetic complete mixture 
drop out mix lacking the appropriate amino acids and nucleic 
acid bases to maintain plasmid selection. In SG (synthetic galac-
tose) and SR (synthetic raffinose) media, glucose was respec-
tively replaced with 2% (w/v) galactose or 1.5% (w/v) raffinose. 
For GAL1 promoter induction, cells were cultured in SR broth 
for 18 h at 30°C, then the appropriate amount of these cultures 
was suspended into fresh SG to reach an OD600 of 0.3, and they 
were incubated for additional 4 - 6 h. Spot growth assays on 
agar were performed as described [4]. 
 
Plasmids 
Transformation of E. coli and yeast and other basic molecular 
biology methods were carried out using standard methods. All 
plasmids and oligonucleotides used are listed in Tables S2 and 
S3, respectively. CDC10 and CDC10-GFP genes were amplified 
by regular PCR from pLA10 plasmid [20] using Cdc10-FW, 
Cdc10-Rv and Cdc10-GFP-Rv primers. PIL1 was amplified from 
S. cerevisiae genomic DNA (BY4741) with Pil1-Fw and Pil1-Rv 
primers. A Gly-Ala (5×) linker was added to the reverse primers 
to facilitate protein folding. All primers were flanked by BamHI 
sites and the resulting inserts were then digested with this en-
zyme and subsequently cloned in frame in plasmid YCpLG-
PI3Kα yielding YCpLG-Cdc10-p110α, YCpLG-Cdc10-GFP-p110α 
and YCpLG-Pil1-p110α.  
DpnI-based site directed mutagenesis was performed using 
the QuikChange kit (Agilent). To generate cdc10-11 allele-con-
taining p110α fusions, the cdc10(G179D) mutation was intro-
duced with primers Cdc10-G179D-Fw and Cdc10-G179D-Rv. 
The YCpLG-Pil1-STOP plasmid was obtained by introducing a 
stop codon in the BamHI restriction site just before the PIK3CA 
gene coding sequence in YCpLG-Pil1-p110α, using the primers 
STOP-p110α-Fw and STOP-p110α-Rv. p110α(K802R) kinase-
dead mutations and the p110α C2-domain mutant C2/4K-A 
(K410A, R412A, K413A, K416A) were obtained with the primers 
previously described [5].  
DRAPIK plasmid: Double marker plasmid pJMCS-DM23 was 
constructed by molecular cloning in the yeast expression plas-
mid pESC-TRP (Agilent). First, GFPx2PH(PLCδ) was amplified by 
PCR with primers GFP-Fw and PH(PLCδ)-Rv using plasmid 
pRS426-GFP2XPH(PLCδ) [35] as template. Then, it was cloned 
in pESC-TRP by using SpeI-BglII restriction sites, yielding the 
plasmid pJMCS-DM20. The PH domain of Akt3 (residues 1-164) 
was amplified by PCR from pYES2-mCherry-Akt3 [13] with pri-
mers Cherry-Fw and PH(Akt3)-Rv and finally cloned into BamHI-
NheI sites of pJMCS-DM20 to generate pJMCS-DM23. 
FLUPI plasmid: To construct the pJMCS-LG3 plasmid express-
ing a LexA-Gal4-PH(Akt3) fusion, a NotI restriction site was arti-
ficially inserted through site-directed mutagenesis with Insert-
NotI-Fw and Insert-NotI-Rv primers into the pEG202-GAL4 plas-
mid (MoBiTec, Germany) disrupting the stop codon of GAL4. 
Then the PH(Akt3) domain was amplified from pJMCS-DM23 
using NotI-PH(Akt3)-Fw and NotI-PH(Akt3)-RV primers and 
cloned into NotI sites of modified pEG202-GAL4, to generate 
pJMCS-LG3. 
 
Microscopy techniques, image processing and statistical  
analysis 
For in vivo fluorescence microscopy (GFP or mCherry), cultures 
subjected to GAL1 induction were concentrated by centrifuga-
tion at 3000 rpm for 2 min and visualized in an Eclipse TE2000U 
Nikon microscope. Digital images were captured with an Orca 
C4742-95-12ER camera and processed with HCImage software 
(Hamamatsu, Hamamatsu, Japan). Endocytosis dynamics was 
monitored by staining with FM4-64 (Fischer Scientific) as previ-
ously reported [36]. 
For DRAPIK assays, fluorescence microscopy images of cells 
co-transformed with pJMCS-DM23 and various YCpLG-p110α 
versions were analyzed as follows: measurements of both red 
(PtdIns3,4,5P3) and green (PtdIns4,5P2) fluorescence intensity 
through a line across one single cell were taken with FiJi soft-
ware [37]. These values were displayed as single-cell densito-
metric histograms. As a quantitative approach, the "normalized 
red:green ratio” was calculated by measuring the fluorescence 
signal for both red and green channels with HCImage in two 
points at opposite sides of the PM and in one in cytoplasm. 
Then, for each channel, each PM fluorescence signal was nor-
malized against the corresponding cytoplasmic fluorescence 
signal from the same cell to generate two PM:cytoplasm ratios 
per cell. The average between them becomes the final ”normal-
ized red:green ratio” for each cell. Thirty randomly chosen cells 
were analyzed for each culture and triplicates of three different 
clones were analyzed. Thus, a total of 90 cells were analyzed 
per p110α version assayed. A two-way ANOVA using Bonferroni 
test was performed with Origin Pro statistics software 
(OriginLab Corp., Northampton, MA, USA).  
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Flow cytometry 
For FLUPI experiments, YPH499 yeast cells bearing pJMCS-LG3, 
pGNG1 and various YCpLG-p110α versions were cultured as for 
fluorescence microscopy analysis. For GFP expression analyses, 
cells were collected after 5 hours of galactose induction, fixed 
with 4% formaldehyde in PBS, washed with PBS and then ana-
lyzed by flow cytometry in Guava easyCyte or CELLQuest 3.3 
(Becton Dickinson) flow cytometers, acquiring green fluores-
cence through a 488 nm excitation laser and a 525/30 BP emis-
sion filter (BFP). Data were processed using FlowJo software 
(FlowJo LLC, Ashland, OR, USA). In order to calculate statistical 
significance, a two-way ANOVA using Bonferroni test was per-
formed with Origin Pro statistics software (OriginLab, North-
ampton, MA, USA).  
For p110α inhibition assays, two-fold serial dilutions of 15e 
(”PI3Kα inhibitor II”, Echelon Biosciences, Salt Lake City, UT, 
USA), LY294002 (Echelon), GDC-0326 (Selleckchem, Houston, 
TX, USA) and ZSTK474 (Selleckchem), were performed in SG 
media. All the compounds were previously dissolved in dime-
thylsulfoxide (DMSO, Sigma-Aldrich) at stock concentrations of 
32 mM, 29 mM, 100 mM and 50 mM, respectively. A negative 
control containing the maximum concentration of DMSO used 
in each assay was included. 200 µL of the yeast preinocula ad-
justed to an OD600 of 1 were added to every tube before incu-
bation in a shaker at 30˚C for 5 h. Inhibition assays were carried 
out as biological triplicates. Cells were collected and processed 
as mentioned above. At least 10,000 cells were analysed for 
each experiment. A green fluorescence ratio was obtained by 
dividing each raw value of mean GFP fluorescence at every con-
centration by the raw value of the DMSO control for each clone. 
Statistical significance was calculated by Student´s t-test. 
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